China Developers to Build $1.5 Billion Life Science Park in South San Francisco

A China real estate developer and several China investment funds will spend $1.5 billion to develop a major biopharma site in South San Francisco, a project that will focus on fostering China-US cooperation in life sciences. The Oyster Point site was acquired by Greenland Holdings, a state-backed developer, plus Agile Group, Ping An Trust and Poly Sino Capital. When fully developed, the site could support over 2.2 million feet of office space, which is expected to be devoted entirely to life science companies. More details.... Share this with colleagues: // //